keeping your oysters business growing has you swamped. you need to hire. i need indeed indeed you do. the moment you sponsor a job on indeed you get a shortlist of quality candidates from a resume data base claim your seventy-five-dollar credit when you post your first job at indeed.com/promo

right now on msnbc breaking news as we come on the air from washington. we're expecting to hear from the fda on the first update from the major news this morning. the recommendation to temporarily pause giving the johnson and johnson vaccine. regulators saying very rare blood clots after the shot, fewer than one in a million. what it means if you're about to get or already got that vaccine. what you need to know about what is very clearly being called a precaution. we're going to take you to that news conference live. another standoff overnight in minnesota after the death of 20-year-old dante wright shot and killed in a traffic stop 10

miles from where george floyd was arrested. we're live with coverage of the derek chauvin trial. and also a fallen capitol police officer going to lie in rotunda. and we're starting with the recommendation to pause the j&j vaccine. this is just audio, and we're going to bring it to you. they are following that recommendation, they're not going to give the j&j vaccine to people for now. they say this is out of an abundance of caution and find

out after the precaution. this is after six reported cases of a rare type of blood clot. that is six out of more than seven million people that have gotten it. the safety and well-being of the people who use our products is our number one priority. so let's go to natalie azar. mike memoli, and lara barrett is in michigan. dr. azar, perspective is so critical here. we're talking some -- almost seven million vaccinations administered from johnson and johnson. you have six rare clots that have happened here. balance out what people need to know and the perspective that is important walking into this. >> good morning, hallie.

certainly this news is extraordinary. as you point out the thing that i really, really to reinforce to folks is this is extremely rare. what we really want to know is does the rate that we're seeing, one in a million, is that above what we would see in the background race for these rare cerebral thrombosis events. of these six individuals, was there predisposing factors? they were women between the age of 18 and 48. were they taking birth control, were they smokers, was there anything that put them at a higher risk for a blood clot like this. i'm not sure we're going to get much information with only six individuals affected. for the vast majority of people the benefits outweigh the risks.

if you're a individual for whom or two this occurs this is significant. we're giving the vaccine to healthy individuals to prevent a severe illness. >> there is a question of what this means as far as the rollout given this pause. i want to go to mike on that, but quickly dr. azar, do we know how long the pause will last? >> what i anticipate happening is they will take a closer look at the cases here in the u.s. as well as cases in the uk and the eu that occurred with the astrazeneca vaccine to see if they can try to find any potential risk factors. the european medical agency in different countries made a recommendation to only administer the johnson and johnson vaccine to older individuals. we may see something like that occur here. again it appears to be more predominantly in females as well

as premenopausal females so there may be a hormonal or gender predisposition. >> i want to listen in now to this press conference. >> we understand these events and also so we can get information out to health care providers and vaccine recipients. right now i would like to stress these events appear to be extremely rare. however, covid-19 vaccine safety is a top priority for the federal government and we take all reports of adverse events following vaccination very seriously. i would like to turn it over to dr. peter marks, the director of research for more information about these reports, peter? >> thank you dr. woodcock.

we are reviewing a rare type of blood clot in combination with low levels of platelets in the blood in women ages 18 to 48 that presents with symptoms six to 13 days after getting the johnson and johnson covid-19 vaccine. treatment of this blood clot it different from typical treatments that usually involve an anti-coagulant. it may be dangerous and alternative treatments may be given preferably under the treatment of doctors familiar with treating these clots.

one person's case was fatal, another was eers. the fda will revise the fact sheet for the health care providers administering the vaccine to include this adverse event information to ensure that health care providers are able to make appropriate benefit risk determinations for their patients. i want to reiterate what dr. woodcock said. right now these events appear to be extremely rare. that said covid-19 vaccine safety is a top priority for federal governments and we take all reports of adverse events following vaccination very seriously. health care providers that see people presenting to them with either a low blood platelet count or blood clots should establish whether or not the individual has recently been vaccinated to inform the appropriate diagnostic.

now we will speak to further explain the decision and next steps. >> thank you so much, dr. marks. i know the information that we're providing today will be very concerning to americans who have already received the johnson and johnson vaccine. and i want to let you know what we're doing to learn more and to protect people in the meantime. and what you can do to be on the alert. as dr. marks mentioned there has been six reports of a severe stroke-like illness with low platelet counts. more than six million doses of the j&j vaccine have been administered so far. while these events are very rare, we're recommending a pause in order to prepare the health care system to recognize and

treat patients appropriately and to report severe events they may be seeing. people who received the vaccine and this pause will also allow the committee to review the situation. the safety of vaccines and the safety of the american people is of the utmost importance to us. the acic, or our advisory committee on immunization practices is the cdc independent scientific expert committee. we are scheduling for them to convene tomorrow to review the data we have on the initial cases. this will allow careful deliberation about what we know so far about these events, and consider next steps given the current context of the covid-19 pandemic in the united states, and our broader immunization

efforts. as a reminder acip meetings are open to public viewing. today we are also alerting state health officials, pharmpharmaci and other health care providers to make sure they know about the pause and so clinicians know how to evaluate and to report severe events after vaccination. lastly i know there are people who got the vaccine that are probably very concerned. for people who got the vaccine more than a month ago, the risk to them is very low at this time. for people who recently got the vaccine in the last couple weeks, they should be aware to look for any symptoms. if you have received the vaccine and developed severe headache, abdominal pain, leg pain, or shortness of breath, you should contact your health care

provider and seek medical treatment. now ahead to symptoms are different from mild flu-like symptoms, fever, and so forth that many people experience in the couple days after receiving the vaccine. importantly there are three vaccines available. we're not seeing clotting events with low platelet counts like the other two vaccines. people who have vaccine appointments with the other two vaccines should continue with their appointments. our partners will be working to reschedule people who have the j&j vaccine appointments in the days ahead. it may be bumpy, we want to make sure we get the word out to the public and to our providers, but we want to make sure that people who are scheduled to have vaccinations wills be able to get that when the vaccine is

available. we're committed to following the science and ensuring the transparency and provide regular updates. we're going to tell you what we know when we know it and what you can do to protect yourself. our intention is to update you in the days ahead. i know that this has been a long and difficult pandemic and a very long year and a half. and that people are tired of the steps they need to take and are keen to be able to be vaccinated. the steps today are meant to make sure that the health care system is ready to diagnosis, treat, and report. and that you, the american public, has the information that you need to stay safe. thank you. >> thank you, doctor. at this time we will begin the question and answer portion of the briefing. when asking a question, please state your name and affiliation,

the operator will take the question. our first question coming from karen stacey, you may go ahead, please state your outlet. >> this looks like the same thing that was happening with the astrazeneca vaccine. i'm wondering if you can tell us a little about the context with regulators in europe about that if there are similar things happenle with pfizer and moderna? >> we're in constant contact with the regulators worldwide and looking at adverse events experienced in different regions. i will turn this over to dr. marks to answer in detail. >> thank you, you ask about similar cases with moderna and pfizer vaccines. there have been over 180 million

doses of those at this time and at this team we have not found any reports of these two events. >> next is michael irwin, you may go head. >> hi, this is mike irwin from reuters. i'm wondering how long the pause is expected to be, what's the minimum time, and if you're considering limiting vaccination for j&j to certain groups like people over 50, or men and women over 50? >> well, the timeframe will depend on what we learn in the next few days. we expect it to be a matter of days for this pause. i will turn it over for a

further answer. >> thank you, we're committed to an e expeditious review. one of the things that the acip deliberation will do is review the data on the cases and the context of the risk benefits and the possible subsets of the population that may be in a different category. i think the intent in the days ahead is to provide a update regularly and that the pause will ensure an appropriate diagnosis and treatment. >> operator will take the next question. >> thank you, our next question coming from elizabeth. you may go ahead, please state your outlet. >> hi. "usa today."

for dr. marks, did you have sense of what the mechanism behind this could be? what could be causing this? >> we have some hypotheses. >> thank you, we don't have a definitive cause, but the probably cause that we believe may be involved here, that we can speculate, is a similar mechanism that may be going on with other vector vaccines. that this is an immune response that occurs very, very rarely after some people receive the vaccine. and that is an immune platelet response. >> the person being vaccinated makes an immune response,

potentially, that involves their own platelets or other parts of their coagulation system. and that is the leading theory or response. >> you may go ahead, please state your outlet. >> hi, thanks for taking questions. can you talk more about how the fda termed these six events, adding almost seven million injections, constitute a signal? what would have been the background rate for an event like this? if there is another explanation possible. >> certainly, this was extensive work between the cdc and the fda

on this set of events and analysis. to see, you know, exactly what you're asking about. dr. marks would you like to answer further on this one? >> yes, thank you. the issue of the cerebral venus thrombosis, the background rate is two to 14 per million people in the setting of a normal platelet count. the combination here that is so notable hoar is not just the cerebral venus thrombosis, it's their occurrence together that makes a pattern and that pattern is very, very similar to what

was seen in europe with another vaccine. so i think we have to take the time to make sure that we understand this complication, and that we address it properly. >> thank you. >> operator will take the next question. >> ann flaherty, you may go ahead, please state your outlet. >> what would you say to people who are concerned and frustrated that they think is might be a overreaction considering it is six people out of seven million? >> i would ask doctor to go into more of that. >> we're committed to safety and transparency and learning as much as we can so that further steps can be taken. when we saw this pattern and we were aware that treatment needed

to be individualized for this condition, it was of the utmost important for us to get the world out. that said the pandemic is quite severe and cases are increases in a lot of places, so we want to make sure that we make some recommendations quickly. >> thank you, operator will take the next question. >> thank you, please state your outlet. >> thank you for taking my question. i'm with cnn. i would like to know more about the decision making process for the pause. it seems like just yesterday we were told that this was something that was being looked into, and then this morning the decision was made and we understand that some states were not given a heads up.

how did this decision happen quickly and why was the decision made? and were states involved given awareness or heads up that the pause would happen? >> sure. dr. marks -- oh, go ahead. >> maybe i can just start and let dr. marks expand. i wish that we had more time to get everyone prepared and that it could go more smoothly. as we know about the issue with appropriate treatment, and it was clear to us that we needed to alert the public. we included the pause in addition to the alert so there was time for the health care community to learn what they needed to learn about how to

diagnose, treat, and report. but the decision was based on the events that might occur between when we made that realization. so we want today be open with our concerns and prepare them to diagnose, treat, and report. >> i don't know if you have anything to ad, dr. marks? >> no, i just echo that the issue here with these types of blood clots is that if one administers the standard treatments that we have learned to give for blood clots, one can actually cause tremendous harm, or the outcome can be fatal. so one needs to make sure that providers are aware that if they see people who have low blood

platelets, or have blood clots, they need to inquire and act accordingly in the diagnosis of those individuals. this was taken rapidly in order to honor our commitment to the american public to sna ur that any safety signal that came up during this rollout was fully addressed in a transparent manner. >> operator will take the next question. >> thank you, caroline chen, please state your outlet. >> i was wonder if there is any sense of histories that could lead a person to this rare side effect or if you have a hypothesis on this at any point. >> i believe there are too few

cases for us to make that determination for this particular vaccine. we may be hearing about more cases. we may look further into these. as just described tomorrow, but we're not prepared at this time to single out any particular sup green group. >> good morning, thank you so much for having this call. i'm with bloomberg law. i'm wondering if you can suggest anything going forward regarding messaging for this. i anticipate that anything that you suggest going forward regarding messaging for this, i would anticipate that, you know,

there could be fears about this stoking more vaccine hesitancy. what do you recommend to help providers avoid that situation? >> so this is janet woodcock again. number one we took several questions about -- related to this. i think we need to reiterate we're committed to vaccination. we feel that is a really important tool to get the pandemic under control. we're also committed to patient safety. our message in doing this is that we feel we're taking a route that will provide the most safety. for them to recognize, properly treat, and dropperly report any events that might happen. but the message to those who

have not been vaccinated would continue to be to get any vaccines available to them. they can be managed properly with this particular vaccine. >> 121 million people have been vaccinated with at least one dose of one of the three vaccines. and the vast majority of the doses were of the other two products. we have not detected with the low platelets among the other

vaccines. we have real world evidence now of the vaccines in the u.s. so we're taking this pause and the precautions around the j&j vaccine. >> thank you, operator will take the next question. >> please state your outlet. >> good morning, this is evan brown from fox news. i'm curious about the choice of words in your announcement. you are recommending a pause in the use of the johnson and johnson vaccine, but you're not ordering a stoppage. is there a difference between the two? what is the difference and what

would happen or what should happen, or what are your words to a state, county, or nonprofit that does not heed that recommendation. >> thank you very much, this is a recommendation, not a mandate. it is out of an abundance of caution. if they have a conversation with a patient and they think it is appropriate, we will not stop that provider from administering that vaccine. in many cases it be will be beneficial overall.

so again, we are recommending a pause out of an abundance of caution, and on a individual basis a individual and a part of this. >> thank you, going back to subgroups. i know there is a few cases now, but is there any sign of risk from breast cancer, and there is six confirmed cases now, but probably more will come out, is there a number -- how many probable cases do you have on the horizon right now? >> dr. marks? >> i'm happy to take this one, yes. thank you very much. so at this time it's not clear

that there is any association with oral contraceptive pill, birth control, and the individuals that had these blood clots. additionally, i think it is too early to make any speculation on how many cases will come out. i do agree with you that it is possible we will learn of more cases, and that is part of the reason why we're taking the pause, to try to ascertain that. but i cannot speculate on how many more we'll learn of. hopefully just going to be a few. >> thank you, go ahead and please state your outlet. >> i'm from cbs and i have two questions. you mentioned that some people may have a conversation with their health care provider and decide that this is appropriate for them, but most people are going to mass vaccination sites

and they don't have that relationship or there are certain risk factors that a individual would know from their medical history. and secondly can you estimate the number of j&j that were expected today be given out, and thousand may effect the vaccination goals of the president? >> would anyone like to respond to that? >> yeah. so let me start with the second question first. i think the vaccine supply has become more abundant overtime. you know i think that this temporary pause is hopefully not going to have a large adverse effect on making those goals in a timely manner if at all. in terms of risk factors, i think that those are, at this

point, i think they are specific enough to a individual that it will have to be a determination with their health care provider. i will turn it over because someone may have more to say about that. >> yes, thank you dr. marks. we're working right now. so right now you're seeing them in women under 50. we need to take time and have immunization practices take additional time to review. my understanding is that it is a predisposing conditions for some of those individuals. and the issue of supply just to

say that currently it provided the minority of doses, there is a possible administer and as rapidly and it is too early to notice the impact on the supply longer term. >> you said there were or were not pre-existing conditions in these cases? >> i tried to say there were not in all of them. there may have been in some, but i think my main point is that but it is difficult to make generalizations. and they are trying to ensure

that providers will report episodes so they can be further investigated but it is large enough that we want to take the pause. >> operator will take our next question. >> thank you. helen branswell, go ahead. >> thank you, this is a question for dr. marks, your remarks suggest that you think this is a class effect. are you looking back through data of the various experimental vaccines produced over the years, and the j and j vaccine, is there data there to help you with this problem?

>> the simple answer is yes. we're going to look at the totality of evidence that informed this, so yes. >> do you think it is a class effect? >> well, we -- i hesitate to call it a class effect but it is obviously to us already that what we're seeing with the vaccines looks very similar to what was being seen with the astrazeneca vaccine. one is that the astrazeneca is a chimpanzee vector, johnson is human vector. so we can't make make a prod statement yet, but they from the same general class of viral

vectors. >> have you asked them to pause the trial? >> i think you can look at one that comes out of j&j today about their valuation actions about and start as a question for a pause. >> you have been listening to the country's top public health officials from the fda on the johnson and johnson vaccination pause due a handful, almost literally, six rare blood clots in people that received the j&j vaccine. no similar impact in the moderna or pfizer vaccine. they say they want it to be expeditious. to let health care providers know what to look for, they have

happened in women between 18 and 48, but they do not believe there is a known link between birth control and those with vaccination issues. as for this pause, at the moment, they say this is a recommendation, not a mandate. they want to level opportunity to work with individual patients on their circumstances and the benefit. dr. azar, i'm going to put you on pause for a moment, we're juggling a few other major pieces of news. one live in minneapolis where the prosecution in the derek chauvin murder trial rested it's case. the other we're showing live on capitol hill, the body of officer billie evans killed in the attack outside of the capitol two fridays ago who will lie in honor at the rotunda. in a matter of moments we will hear from president biden, from nancy pelosi, and others.

officer evans family will be there for the memorial service as well. just to remind you, a suspect drove up his car and shot and killed him. they don't know a motive but they don't believe it was terror related. he came out of the vehicle with a knife. officer evans was killed in that attack. he was a capitol police officer for 18 years, killed at the age of 41. i want to bring on garrett haake. kel you tell us what we're talking about so far here. there is a few hundred capitol police officers that have been

saluting it. they built up more people as the pandemic now allows it. it is not going to be a long ceremony, he will only lie in honor for the duration of the day today, but i do expect it to be emotional here. from the president that really speaks to the issue of personal grief fluently as well as the speaker of the house and the majority leader schumer. the family of often e officer evans and his two young sons, their chairs having tiny models of the capitol. and when this happened the house and senate were in rerecess, the

was barely anyone here. they know what the capitol police have been through, they know how exhausted they have been by the events of this year and an opportunity for collective mourning this year will be very important. >> a senate sergeant in harms. >> good morning, thank you for covering this. >> of course, you knew officer evans, you swore him in? >> yes, some 18 years ago. i remember that smile he had and such enthuenthusiasm. i also served with him for about four years. i ran into him often because he was generally on the senate side at that north barricade where there is a lot of interaction

with him. i served with him with honor and it's heartbreak what everyone there is going through. >> can you tell us more about him, chief? >> i know this. he was very serious about his work, but he had a wonderful disposition. the doctors that have i spoken to since his death, and his commanding officer, they all have very positive things to say about him. probably more active on facebook because of kids and grandkids, and all of the posings i saw was that he was hard working, a great sense of humor, and he could always be counted on just like he was just days ago when he was outside of the barricade ready to respond to any threat. he was a good man. >> that's what we keep hearing

over and over again. his family, his friends, talking about what a good father he was taking every opportunity to spend spinal with his friends. the small scale models of the capitol. >> there was another thing about his children -- >> go ahead. >> one of the other officers were telling me that when they brought the remains from him to one spot to another, they had capitol police shirts on. and the officers described how heartbreaking that was. for them to see that. >> it is heartbreaking to even hear about it, chief. that's one of the reasons that we're bringing this to you live. we expect the casket to make it's way up the stairs. he prepares to lie in honor.

i want to bring in kristin welker. we're seeing president biden now lead the country as a consoler in chief when it comes to a police force that he knows so well in his many years in congress. and a police force that is reeling after what happened on january 6th, what happened then, and the attack this month. >> you're absolutely right, and i think you lay out the backdrop exactly perfectly. for president biden this is to some extent personal. because of the decades that he served on capitol hill as a senator. and i just spoke with a white house official who said he will talk about the enormity of the loss. he will talk about the sacrifice and the burden. particularly in this unique

climate that we live in. i don't think he will comment about the tragic events of january 6th, but it will be implied that ever since this day these officers have carried increasingly more heavy burden on their shoulders. he will also talk about the courage, the duty, and he will extend his condolences to the family. no surprise there, but i'm told he is really going to talk about the fact that these are sacrifices made by the families of these capitol police officers as well. every day they don't know if their loved ones will be returning home. the remarks will be five to ten minutes in length. but i think what you can anticipate is somber remarks, serious remarks, laying out the backdrop against which this tragedy occurred, hallie. >> kristin, thank you. i want to bring in pete williams.

you have been following the investigations into what happened in both of those capitol attacks. not just the siege, but what we saw earlier this month. what is being done in those investigations? any update? and to address some of the security concerns around the capitol? >> the security concerns around the capitol remain largely unresolved. there has been no real decision about what to do based largely on the january 6th attack. the temporary fencing that was way out beyond the capitol is gone. now there is just fencing around the capitol. additional national guard troops will stay at least in the president goes to his hill to make an address to the joint session of congress. and then the question is what about after that? the recommendations have been made for temporary fencing that can be deployed. a quick reaction force. better intelligence assets in the capitol police itself, and

perhaps a streamlined ability to make decisions instead of using what is considered to be the creeky structure with the capitol police board that does not give the chief very much discretion to make decisions in the short-term. the force is also seriously understaffed. there is a large vacancy. many people say the events of the year have been demoralizing and some are considering leaving before their normal terms would expire. the capitol police here face very serious decisions and the members of congress who ultimately will make the decisions have not decided what they will be. >> chief gainer, can you talk about your sense of morale? >> i think you're in a tough position losing two officers in three months. many of those officers were

there in 1998 when two more officers were killed. officer j.j. chestnut and john gibson. several of them have followed up with the event of sergeant chris penny who was killed nearly 20 years ago. they feel all of this in a community. they are tired from the long hours. they're short some 230 officers. many have been working days off. many have been working 12 and 16 hours a day. they're still reeling from the attack that happened. those that were there are hurting, and there are still people hurting from that. officers are there, but they were not serving that day and they feel somewhat guiltiy. again as both pete and jared said, no action has been really taken to the recommendations. we had some 100 recommendations.

it's about where are we seeing progress. i know that with the highing process, the lieutenant general in the army, well steeped in intelligence, i know that is being improved. all of the other things that would help the officers and make it safer have already been done. >> thank you, i want to ask you to stand by for just a moment. we talked about the multiple live news events happening this hour. another as we continue to watch the start of this service. the defense has now gun their portion of the final arguments in the chauvin trial. let's listen in.

>> he stood next to the scar, right? >> yes, ma'am. >> he asked you not to beat him up, correct? >> that's correct, yes. >> he was able to walk, yes? >> yes. >> he he was. >> he continued to talk to you? >> yes. >> wick sidebar here. and we should note that the witness on the stand right now is scott creten, a retired minneapolis police officer. again, the first witness that the defense has called.

you are now watching a bit of the prosecution cross-examination, or the redirect, as we call it. that is where we stand. creten is the officer who interacted with floyd back in 2019. this is part of the defense strategy as they present their case. we expect this sidebar to wrap up in just a moment. the prosecution spent over a week laying out the emotional response to the bystanders and the witnesses who watched the death of george floyd, derek chauvin, as many have testified, putting his knee on the neck of mr. floyd. after that, they moved into specifically looking at the medical examiner reports and the use of force with a slew of witnesses testifying specifically on whether chauvin acted appropriately. the prosecution is arguing that he did not and his use of force was excessive in the death of george floyd. i believe we have danny cevallos

with us. danny -- actually, the sidebar is ending, so we'll dip you back into the trial. >> mrs. aldridge, if you would. >> thank you, your honor. officer creten, you were describing you got mr. floyd out of car, correct? >> yes. >> and he stood next to the car and you handcuffed him, correct? >> me and another officer had to physically handcuff him, correct? >> he didn't fall down? >> no, he didn't fall down. >> nothing further, your honor. >> anything further. >> officer creighton, there was another officer on the driver's side dealing with the driver? >> yes, that's correct. actually, two. >> and that officer was speaking to or giving commands to the driver? >> that's correct. >> simultaneous to the time that you were giving commands to mr. floyd. >> that's correct. >> did you hear the officer say "spit it out"? >> i may have, yes. i -- you would have to see the

video, and if that's what the video shows, then that's what occurred. >> i have no further questions. >> anything further? >> nothing, your honor. >> officer creighton, you were just asked some questions about what the other officers were doing. you were interacting with mr. floyd, correct? >> yes. >> and while you were interacting with mr. floyd, he didn't collapse on the ground, correct? >> what was the question? can you speak up a little louder, ma'am? >> while you were interacting with mr. floyd, he didn't collapse on the ground, correct? >> well, the answer is answered. the objection sustained. >> you were asked some questions about what the other officers were doing, correct? >> that's correct. >> your attention was focused on mr. floyd, correct? >> yes, it was. >> and mr. floyd didn't drop dead while you were interacting with him, correct? >> no. >> thank you. nothing further. >> anything further? >> no, your honor. >> thank you, you may step down. >> thank you, your honor.

>> next witness. >> the defense calls michelle mosing. >> you can stand right there for a second. raise your right hand. do you swear or affirm under the penalty of perjury that the testimony will be the truth and nothing but the truth? >> have a seat.

>> skpf before you begin, if you could state your full name, spell each of your names, and hold off -- just give your full name and spell each name. >> first name is michelle, m-i-c-h-e-l-l-e. last name is mos -- >> we are going to break away from the defense in the derek chauvin trial as the defense's second witness gets ready to take the stand, because we want to bring you back to what is happening live here in washington. in that little box in the corner of your screen is about to get a lot bigger. that is the ceremony for officer billy evans. you can see his two kids, his son, logan, looking like he's holding a teddy bear. his daughter, abigail, there on the stairs, as well, with their -- i believe that's their mother, shannon. the body of officer evans, his casket draped in the u.s. flag, being prepared to be marched up the stairs and into the rotunda,

where he will lie in honor after being killed by an attacker at the capitol earlier this month. we expect to hear from president biden and others at the memorial service beginning in just moments. we want to take a moment and just watch.

>> it is almost unimaginable heartbreak for the members of the capitol police force, some of who you have been looking at live, as one of their own, an 18-year veteran of the u.s. capitol police officer billy evans is brought into the capitol rotunda, where he will lie in honor. in just a moment, we expect to hear from president biden, from house speaker pelosi and others honoring the life and the service of officer evans. we're going to stay in this live, but i want to hand it over to my colleague jeff bennett who will pick up our coverage now. jeff? >> good tuesday morning to you. i'm jeff bennett in for craig melvin. we are having our eyes right now on the capitol rotunda, where fa